PROCEPT BioRobotics Corp (PRCT) research
PROCEPT BioRobotics Corp- Sector
- Health Care
- Last price
- $19.44
- As of
PROCEPT BioRobotics Corp (PRCT): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-05.
As of . Source: SEC EDGAR filings for PRCT. Method and limitations.
Share the PRCT intelligence card
See PRCT live in the terminal
Track PRCT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live PRCT terminal, freeActive signals for PRCT
- highCONSENSUS_BUY
3 tracked funds increased PRCT this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 75% of PRCT (2026Q2)
- highINSTITUTIONAL_EXIT
TWO SIGMA INVESTMENTS, LP cut 91% of PRCT (2026Q2)
- highINSTITUTIONAL_EXIT
TWO SIGMA INVESTMENTS, LP cut 78% of PRCT (2026Q2)
- highINSTITUTIONAL_EXIT
TWO SIGMA INVESTMENTS, LP cut 93% of PRCT (2026Q2)
FREE, NO ACCOUNT
Every signal on PRCT, as it fires
You are seeing 5 of 22 signals recorded on PRCT since 2026-05-17.
The five above landed across 2 days. The other 17 were recorded on 3 other days. 18 of the 22 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PRCT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 74276L105 · 2026Q2 | $14.1M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 74276L105 · 2026Q2 | $1.2M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 74276L105 · 2026Q2 | $285K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PRCT
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
PRCT against its peers
PRCT's operating margin of -33.7% ranks in the 6th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-10-03 and 2026-05-31.
| Metric | PRCT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 308M USD | 764M USD | 25 | 25 |
| Gross margin | 63.7% | 54.6% | 56 | 16 |
| Operating margin | -33.7% | 0.4% | 6 | 25 |
| Net margin | -31.0% | -2.2% | 6 | 25 |
| Return on equity | -26.1% | -4.7% | 17 | 25 |
| P / E | n/a | 47.2x | n/a | 9 |
Peers (25): IRMD, CSTL, GDRX, TDOC, STAA, TNDM, USPH, CERT, OMDA, AMN, BVS, CNMD, PNTG, TALK, HSTM, OMCL, VREX, ATEC, AHCO, EHAB, LMAT, ANGO, NVCR, XRAY, FLGT. Fiscal periods ending between 2025-10-03 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (PRCT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PRCT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PRCTand get the insider, 13F, options, and confluence read in one view.